Report Summary
Molecular Diagnostics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in United States, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the United States Molecular Diagnostics market as:
United States Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PCR
DNA Sequencing
NGS
United States Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Infectious Disease (Hepatitis, HIV)
Oncology
Genetic Testing
United States Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
ABBOTT LABORATORIES
AGILENT TECHNOLOGIES
BECTON, DICKINSON AND COMPANY
BIOMERIEUX
DANAHER
DIASORIN
GRIFOLS
HOLOGIC
ILLUMINA
QIAGEN
ROCHE DIAGNOSTICS
SIEMENS
THERMO FISHER SCIENTIFIC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Interested in this report?
Get your sample now!
Table of Contents
Chapter 1 Overview of Molecular Diagnostics
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 PCR
1.2.2 DNA Sequencing
1.2.3 NGS
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Infectious Disease (Hepatitis, HIV)
1.3.2 Oncology
1.3.3 Genetic Testing
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 United States Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
Chapter 2 United States Market Status and Forecast by Regions
2.1 Market Status of Molecular Diagnostics in United States 2013-2017
2.2 Consumption Market of Molecular Diagnostics in United States by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in United States by Regions
2.2.2 Revenue of Molecular Diagnostics in United States by Regions
2.3 Market Analysis of Molecular Diagnostics in United States by Regions
2.3.1 Market Analysis of Molecular Diagnostics in New England 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in The Midwest 2013-2017
2.3.4 Market Analysis of Molecular Diagnostics in The West 2013-2017
2.3.5 Market Analysis of Molecular Diagnostics in The South 2013-2017
2.3.6 Market Analysis of Molecular Diagnostics in Southwest 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in United States 2018-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in United States 2018-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023
Chapter 3 United States Market Status and Forecast by Types
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in United States by Types
3.1.2 Revenue of Molecular Diagnostics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Molecular Diagnostics in United States by Types
Chapter 4 United States Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Molecular Diagnostics in United States by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in New England
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Molecular Diagnostics by Downstream Industry in The West
4.2.5 Demand Volume of Molecular Diagnostics by Downstream Industry in The South
4.2.6 Demand Volume of Molecular Diagnostics by Downstream Industry in Southwest
4.3 Market Forecast of Molecular Diagnostics in United States by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Molecular Diagnostics
5.1 United States Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
Chapter 6 Molecular Diagnostics Market Competition Status by Major Players in United States
6.1 Sales Volume of Molecular Diagnostics in United States by Major Players
6.2 Revenue of Molecular Diagnostics in United States by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Molecular Diagnostics Major Manufacturers Introduction and Market Data
7.1 ABBOTT LABORATORIES
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES
7.2 AGILENT TECHNOLOGIES
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES
7.3 BECTON, DICKINSON AND COMPANY
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY
7.4 BIOMERIEUX
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX
7.5 DANAHER
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER
7.6 DIASORIN
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN
7.7 GRIFOLS
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS
7.8 HOLOGIC
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC
7.9 ILLUMINA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA
7.10 QIAGEN
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN
7.11 ROCHE DIAGNOSTICS
7.11.1 Company profile
7.11.2 Representative Molecular Diagnostics Product
7.11.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS
7.12 SIEMENS
7.12.1 Company profile
7.12.2 Representative Molecular Diagnostics Product
7.12.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS
7.13 THERMO FISHER SCIENTIFIC
7.13.1 Company profile
7.13.2 Representative Molecular Diagnostics Product
7.13.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC
Chapter 8 Upstream and Downstream Market Analysis of Molecular Diagnostics
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Molecular Diagnostics
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
Chapter 10 Marketing Status Analysis of Molecular Diagnostics
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
List of Tables
Table Advantage and Disadvantage of PCR
Table Advantage and Disadvantage of DNA Sequencing
Table Advantage and Disadvantage of NGS
Table Consumption Volume of Molecular Diagnostics in United States by Regions 2013-2017
Table Revenue of Molecular Diagnostics in United States by Regions 2013-2017
Table Consumption Volume of Molecular Diagnostics in United States by Regions 2018-2023
Table Revenue of Molecular Diagnostics in United States by Regions 2018-2023
Table Consumption Volume of Molecular Diagnostics in United States by Types 2013-2017
Table Revenue of Molecular Diagnostics in United States by Types 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in New England 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in The Middle Atlantic 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in The Midwest 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in The West 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in The South 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in Southwest 2013-2017
Table Consumption Volume Forecast of Molecular Diagnostics in United States by Types 2018-2023
Table Revenue Forecast of Molecular Diagnostics in United States by Types 2018-2023
Table Demand Volume of Molecular Diagnostics in United States by Downstream Industry 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in New England 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in The Middle Atlantic 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in The Midwest 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in The West 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in The South 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in Southwest 2013-2017
Table Demand Volume Forecast of Molecular Diagnostics in United States by Downstream Industry 2018-2023
Table Sales Volume of Molecular Diagnostics in United States by Major Players 2013-2017
Table Revenue of Molecular Diagnostics in United States by Major Players 2013-2017
Table Headquarters Location and Established Time of Molecular Diagnostics Major Players
Table Employees and Revenue Level of Molecular Diagnostics Major Players
Table Representative Molecular Diagnostics Product One of ABBOTT LABORATORIES
Table Representative Molecular Diagnostics Product Two of ABBOTT LABORATORIES
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES 2013-2017
Table Representative Molecular Diagnostics Product One of AGILENT TECHNOLOGIES
Table Representative Molecular Diagnostics Product Two of AGILENT TECHNOLOGIES
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES 2013-2017
Table Representative Molecular Diagnostics Product One of BECTON, DICKINSON AND COMPANY
Table Representative Molecular Diagnostics Product Two of BECTON, DICKINSON AND COMPANY
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY 2013-2017
Table Representative Molecular Diagnostics Product One of BIOMERIEUX
Table Representative Molecular Diagnostics Product Two of BIOMERIEUX
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX 2013-2017
Table Representative Molecular Diagnostics Product One of DANAHER
Table Representative Molecular Diagnostics Product Two of DANAHER
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER 2013-2017
Table Representative Molecular Diagnostics Product One of DIASORIN
Table Representative Molecular Diagnostics Product Two of DIASORIN
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN 2013-2017
Table Representative Molecular Diagnostics Product One of GRIFOLS
Table Representative Molecular Diagnostics Product Two of GRIFOLS
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS 2013-2017
Table Representative Molecular Diagnostics Product One of HOLOGIC
Table Representative Molecular Diagnostics Product Two of HOLOGIC
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC 2013-2017
Table Representative Molecular Diagnostics Product One of ILLUMINA
Table Representative Molecular Diagnostics Product Two of ILLUMINA
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA 2013-2017
Table Representative Molecular Diagnostics Product One of QIAGEN
Table Representative Molecular Diagnostics Product Two of QIAGEN
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN 2013-2017
Table Representative Molecular Diagnostics Product One of ROCHE DIAGNOSTICS
Table Representative Molecular Diagnostics Product Two of ROCHE DIAGNOSTICS
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS 2013-2017
Table Representative Molecular Diagnostics Product One of SIEMENS
Table Representative Molecular Diagnostics Product Two of SIEMENS
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS 2013-2017
Table Representative Molecular Diagnostics Product One of THERMO FISHER SCIENTIFIC
Table Representative Molecular Diagnostics Product Two of THERMO FISHER SCIENTIFIC
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC 2013-2017
